An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
BACKGROUND:<br/> The artemisinin-based combination treatment (ACT) of dihydroartemisinin (DHA) and piperaquine (PQP) is a promising novel anti-malarial drug effective against multi-drug resistant falciparum malaria. The aim of this study was to show non-inferiority of DHA/PQP vs. artesunate-m...
Главные авторы: | Valecha, N, Phyo, A, Mayxay, M, Newton, P, Krudsood, S, Keomany, S, Khanthavong, M, Pongvongsa, T, Ruangveerayuth, R, Uthaisil, C, Ubben, D, Duparc, S, Bacchieri, A, Corsi, M, Rao, B, Bhattacharya, P, Dubhashi, N, Ghosh, S, Dev, V, Kumar, A, Pukrittayakamee, S |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Public Library of Science
2010
|
Схожие документы
-
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
по: Valecha, N, и др.
Опубликовано: (2010) -
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
по: Neena Valecha, и др.
Опубликовано: (2010-01-01) -
Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
по: Neena Valecha, и др.
Опубликовано: (2010-01-01) -
Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
по: Neena Valecha, и др.
Опубликовано: (2010-01-01) -
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
по: Mayxay, M, и др.
Опубликовано: (2010)